{"title":"四极气相色谱-负离子化学电离-串联质谱法分析五氟苯三甲基硅基衍生物:命名墨菲重排","authors":"Dimitrios Tsikas","doi":"10.1016/j.jchromb.2025.124794","DOIUrl":null,"url":null,"abstract":"<div><div>Eicosatetraenoic acid (arachidonic acid) is the precursor of the eicosanoids, which include the prostaglandins (PGs), the leukotrienes (LTs), and the endocannabinoids (ECs). Methods based on GC–MS/MS are the <em>Gold Standard</em> for the quantitative analysis of eicosanoids in biological samples. After extraction and derivatization, biological eicosanoids are analyzed on quadrupole GC–MS/MS apparatus as pentafluorobenzyl (PFB) ester trimethylsilyl (TMS) ether derivatives, i.e., PFB-TMS. Negative-ion chemical ionization (NICI) generates in the ion-source abundant anions due to [M–PFB]<sup>−</sup>. Collision-induced dissociation (CID) of [M–PFB]<sup>−</sup> in the collision cell generates product ions, which are suitable candidates for specific quantitative analyses in the selected-reaction monitoring (SRM) mode. In this article, we review CID gas-phase reactions of PFB-TMS derivatives of PGs and LTs. The specific CID negative charge-driven intramolecular rearrangement of TMS groups from ether moieties (OTMS) to carboxylate anions [M–PFB]<sup>−</sup> of PFB-TMS derivatives to form a –COO-TMS ester has been reported for the first time by Robert C. Murphy on PFB-TMS derivatives of 5-hydroxy-eicosanoic acid (HEA) from hydrogenated and desulfurized LTE<sub>4</sub>, and saturated LTB<sub>4</sub>. We propose to name this specific CID gas-phase reaction the <em>Murphy Rearrangement</em> in honour of R.C. Murphy. The <em>Murphy Rearrangement</em> generates the product ions <em>m/z</em> 253 and <em>m/z</em> 89 from the precursor ion <em>m/z</em> 399 of the PFB-TMS derivative of HEA and neutral loss of 146 Da. We propose to name <em>Murphy-type Rearrangements</em> that were observed for the eicosanoids 8-<em>iso</em>PGF<sub>2α</sub>, its 2,3-dinor- and 2,3-dinor-5,6-dihydro-metabolites, the major urinary metabolites (MUM) of F and E prostaglandins, i.e., PGF-MUM and PGE-MUM, respectively, as well as for the CID of <em>m/z</em> 179 [M–PFB]<sup>−</sup> of the PFB ester of the drug acetylsalicylic acid (aspirin). The <em>Murphy Rearrangement</em> and <em>Murphy-type Rearrangements</em> differ with respect to the rearrangement ion and the subsequent neutral losses and fragmentations. The <em>Murphy-type Rearrangements</em> of PGF-MUM and PGE-MUM includes a specific neutral loss of 198 Da PFBOH due to intramolecular attack of 1- or ω-COO<sup>−</sup> anions to ω- or 1-COO-PFB esters. <em>Murphy Rearrangements</em> and <em>Murphy-type Rearrangements</em> are best identified by performing CID studies on PFB-TMS derivatives of [1,1-<sup>18</sup>O<sub>2</sub>]- and [1,ω-<sup>18</sup>O<sub>2</sub>]-eicosanoids in the NICI mode. Neutral loss of TMS<sup>18</sup>OH (92 Da) and PFB<sup>18</sup>OH (200 Da) (in dicarboxy-eicosanoids), and formation of a product ion with <em>m/z</em> 91 [TMS<sup>18</sup>O]<sup>−</sup> will indicate <em>Murphy Rearrangements</em> and <em>Murphy-type Rearrangements.</em> Formation of a product ion with <em>m/z</em> 59 (acetate) from the CID of <em>m/z</em> 179 [M–PFB]<sup>−</sup> of the PFB ester of acetylsalicylic acid will be indicative of a <em>Murphy-type Rearrangement</em>.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1267 ","pages":"Article 124794"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Analysis of eicosanoids by quadrupole gas chromatography-negative ion chemical ionization-tandem mass spectrometry as pentafluorobenzyl trimethylsilyl derivatives: Naming the Murphy rearrangement\",\"authors\":\"Dimitrios Tsikas\",\"doi\":\"10.1016/j.jchromb.2025.124794\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Eicosatetraenoic acid (arachidonic acid) is the precursor of the eicosanoids, which include the prostaglandins (PGs), the leukotrienes (LTs), and the endocannabinoids (ECs). Methods based on GC–MS/MS are the <em>Gold Standard</em> for the quantitative analysis of eicosanoids in biological samples. After extraction and derivatization, biological eicosanoids are analyzed on quadrupole GC–MS/MS apparatus as pentafluorobenzyl (PFB) ester trimethylsilyl (TMS) ether derivatives, i.e., PFB-TMS. Negative-ion chemical ionization (NICI) generates in the ion-source abundant anions due to [M–PFB]<sup>−</sup>. Collision-induced dissociation (CID) of [M–PFB]<sup>−</sup> in the collision cell generates product ions, which are suitable candidates for specific quantitative analyses in the selected-reaction monitoring (SRM) mode. In this article, we review CID gas-phase reactions of PFB-TMS derivatives of PGs and LTs. The specific CID negative charge-driven intramolecular rearrangement of TMS groups from ether moieties (OTMS) to carboxylate anions [M–PFB]<sup>−</sup> of PFB-TMS derivatives to form a –COO-TMS ester has been reported for the first time by Robert C. Murphy on PFB-TMS derivatives of 5-hydroxy-eicosanoic acid (HEA) from hydrogenated and desulfurized LTE<sub>4</sub>, and saturated LTB<sub>4</sub>. We propose to name this specific CID gas-phase reaction the <em>Murphy Rearrangement</em> in honour of R.C. Murphy. The <em>Murphy Rearrangement</em> generates the product ions <em>m/z</em> 253 and <em>m/z</em> 89 from the precursor ion <em>m/z</em> 399 of the PFB-TMS derivative of HEA and neutral loss of 146 Da. We propose to name <em>Murphy-type Rearrangements</em> that were observed for the eicosanoids 8-<em>iso</em>PGF<sub>2α</sub>, its 2,3-dinor- and 2,3-dinor-5,6-dihydro-metabolites, the major urinary metabolites (MUM) of F and E prostaglandins, i.e., PGF-MUM and PGE-MUM, respectively, as well as for the CID of <em>m/z</em> 179 [M–PFB]<sup>−</sup> of the PFB ester of the drug acetylsalicylic acid (aspirin). The <em>Murphy Rearrangement</em> and <em>Murphy-type Rearrangements</em> differ with respect to the rearrangement ion and the subsequent neutral losses and fragmentations. The <em>Murphy-type Rearrangements</em> of PGF-MUM and PGE-MUM includes a specific neutral loss of 198 Da PFBOH due to intramolecular attack of 1- or ω-COO<sup>−</sup> anions to ω- or 1-COO-PFB esters. <em>Murphy Rearrangements</em> and <em>Murphy-type Rearrangements</em> are best identified by performing CID studies on PFB-TMS derivatives of [1,1-<sup>18</sup>O<sub>2</sub>]- and [1,ω-<sup>18</sup>O<sub>2</sub>]-eicosanoids in the NICI mode. Neutral loss of TMS<sup>18</sup>OH (92 Da) and PFB<sup>18</sup>OH (200 Da) (in dicarboxy-eicosanoids), and formation of a product ion with <em>m/z</em> 91 [TMS<sup>18</sup>O]<sup>−</sup> will indicate <em>Murphy Rearrangements</em> and <em>Murphy-type Rearrangements.</em> Formation of a product ion with <em>m/z</em> 59 (acetate) from the CID of <em>m/z</em> 179 [M–PFB]<sup>−</sup> of the PFB ester of acetylsalicylic acid will be indicative of a <em>Murphy-type Rearrangement</em>.</div></div>\",\"PeriodicalId\":348,\"journal\":{\"name\":\"Journal of Chromatography B\",\"volume\":\"1267 \",\"pages\":\"Article 124794\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-09-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Chromatography B\",\"FirstCategoryId\":\"1\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1570023225003484\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Chromatography B","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1570023225003484","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
Analysis of eicosanoids by quadrupole gas chromatography-negative ion chemical ionization-tandem mass spectrometry as pentafluorobenzyl trimethylsilyl derivatives: Naming the Murphy rearrangement
Eicosatetraenoic acid (arachidonic acid) is the precursor of the eicosanoids, which include the prostaglandins (PGs), the leukotrienes (LTs), and the endocannabinoids (ECs). Methods based on GC–MS/MS are the Gold Standard for the quantitative analysis of eicosanoids in biological samples. After extraction and derivatization, biological eicosanoids are analyzed on quadrupole GC–MS/MS apparatus as pentafluorobenzyl (PFB) ester trimethylsilyl (TMS) ether derivatives, i.e., PFB-TMS. Negative-ion chemical ionization (NICI) generates in the ion-source abundant anions due to [M–PFB]−. Collision-induced dissociation (CID) of [M–PFB]− in the collision cell generates product ions, which are suitable candidates for specific quantitative analyses in the selected-reaction monitoring (SRM) mode. In this article, we review CID gas-phase reactions of PFB-TMS derivatives of PGs and LTs. The specific CID negative charge-driven intramolecular rearrangement of TMS groups from ether moieties (OTMS) to carboxylate anions [M–PFB]− of PFB-TMS derivatives to form a –COO-TMS ester has been reported for the first time by Robert C. Murphy on PFB-TMS derivatives of 5-hydroxy-eicosanoic acid (HEA) from hydrogenated and desulfurized LTE4, and saturated LTB4. We propose to name this specific CID gas-phase reaction the Murphy Rearrangement in honour of R.C. Murphy. The Murphy Rearrangement generates the product ions m/z 253 and m/z 89 from the precursor ion m/z 399 of the PFB-TMS derivative of HEA and neutral loss of 146 Da. We propose to name Murphy-type Rearrangements that were observed for the eicosanoids 8-isoPGF2α, its 2,3-dinor- and 2,3-dinor-5,6-dihydro-metabolites, the major urinary metabolites (MUM) of F and E prostaglandins, i.e., PGF-MUM and PGE-MUM, respectively, as well as for the CID of m/z 179 [M–PFB]− of the PFB ester of the drug acetylsalicylic acid (aspirin). The Murphy Rearrangement and Murphy-type Rearrangements differ with respect to the rearrangement ion and the subsequent neutral losses and fragmentations. The Murphy-type Rearrangements of PGF-MUM and PGE-MUM includes a specific neutral loss of 198 Da PFBOH due to intramolecular attack of 1- or ω-COO− anions to ω- or 1-COO-PFB esters. Murphy Rearrangements and Murphy-type Rearrangements are best identified by performing CID studies on PFB-TMS derivatives of [1,1-18O2]- and [1,ω-18O2]-eicosanoids in the NICI mode. Neutral loss of TMS18OH (92 Da) and PFB18OH (200 Da) (in dicarboxy-eicosanoids), and formation of a product ion with m/z 91 [TMS18O]− will indicate Murphy Rearrangements and Murphy-type Rearrangements. Formation of a product ion with m/z 59 (acetate) from the CID of m/z 179 [M–PFB]− of the PFB ester of acetylsalicylic acid will be indicative of a Murphy-type Rearrangement.
期刊介绍:
The Journal of Chromatography B publishes papers on developments in separation science relevant to biology and biomedical research including both fundamental advances and applications. Analytical techniques which may be considered include the various facets of chromatography, electrophoresis and related methods, affinity and immunoaffinity-based methodologies, hyphenated and other multi-dimensional techniques, and microanalytical approaches. The journal also considers articles reporting developments in sample preparation, detection techniques including mass spectrometry, and data handling and analysis.
Developments related to preparative separations for the isolation and purification of components of biological systems may be published, including chromatographic and electrophoretic methods, affinity separations, field flow fractionation and other preparative approaches.
Applications to the analysis of biological systems and samples will be considered when the analytical science contains a significant element of novelty, e.g. a new approach to the separation of a compound, novel combination of analytical techniques, or significantly improved analytical performance.